Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
8.91
-0.03 (-0.34%)
At close: May 14, 2026, 4:00 PM EDT
8.81
-0.10 (-1.12%)
After-hours: May 14, 2026, 5:29 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $652.84 million as of May 14, 2026. Its market cap has increased by 173.77% in one year.
Market Cap
652.84M
Enterprise Value
494.82M
1-Year Change
173.77%
Ranking
Category
Stock Price
$8.91
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $652.84M, an increase of 193.56%. That is a compound annual growth rate of 25.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 655.04M | 111.18% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 701.24M |
| Eikon Therapeutics | 666.45M |
| Gyre Therapeutics | 665.19M |
| Zevra Therapeutics | 657.36M |
| Sutro Biopharma | 656.09M |
| Kyverna Therapeutics | 652.52M |
| Crescent Biopharma | 651.62M |
| BridgeBio Oncology Therapeutics | 646.67M |